Post

We welcome today’s Supreme Court decision to grant a stay in Louisiana v FDA. Hey Jane continues to provide access to high quality, safe and effective abortion care.

Hey Jane

@heyjane.com

14 May

Courts should not interfere with FDA’s expert decisions allowing mifepristone to be prescribed by telehealth—and patients should not have to navigate legal chaos to continue accessing safe, legal medication abortion through Hey Jane.

Hey Jane

@heyjane.com

This case is the latest step in an ongoing effort to disrupt access to the gold standard medication abortion regimen—mifepristone and misoprostol—despite decades of scientific evidence and safety reviews.

14/5/26, 10:49 pm0 reposts0 likes

Hey Jane

@heyjane.com

14 May

Restricting patients’ options would not make patients safer. The point of baseless litigation like this is to sow confusion and uncertainty for patients seeking time-sensitive care.

Hey Jane

@heyjane.com

14 May

At Hey Jane, we’ve cared for more than 100,000 patients, and our experience continues to reinforce the strong safety record behind this model of care.

Hey Jane

@heyjane.com

14 May

Hey Jane exists because patients deserve private, timely, evidence-based health care without unnecessary barriers. We remain unwavering in our commitment to providing safe, compassionate abortion care and meeting patients where they are when they need us.